Jiangsu Sihuan Bioengineering Hits 52‑Week High, Driving Growth in China’s Biotech Sector
Jiangsu Sihuan Bioengineering: a Chinese biotech leader with $4.25 B market cap, 52‑week high stock price, and a future‑focused R&D strategy to boost profitability and industry impact.
- Jiangsu Sihuan Bioengineering Co Ltd
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read